Carregant...
Targeting the oncogenic activity of TCF3-HLF in leukemia
The oncogenic fusion transcription factor TCF3-HLF identifies an aggressive subtype of acute lymphoblastic leukemia. TCF3-HLF imposes a malignant program by activation of lineage-specific oncogenic enhancers. Among critical cofactors of the TCF3-HLF complex we identified EP300, which functional inhi...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7199759/ https://ncbi.nlm.nih.gov/pubmed/32391417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2019.1709391 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|